Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mehy.2020.110202 http://scihub22266oqcxt.onion/10.1016/j.mehy.2020.110202 33254510!7434307!33254510     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33254510&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Med+Hypotheses 2020 ; 144 (?): 110202 Nephropedia Template TP {{tp|p=33254510|t=2020. Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19?|pdf=|usr=}}{{33254510}} gab.com Text Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19 JO: Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=33254510 #FOAvip Toll-like receptor 7 is critical in recognition of single strand RNA viruses, including SARS CoV-2, and generation of anti-viral immunity. Coronaviruses evolved strategies to dampen the host immunity. Herein, we discuss the potential use of TLR7 agonists in the early stages of COVID-19 treatment. Twit Text FOAVip Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19 ????Med Hypotheses http://www.kidney.de/pget.php?&tw=1&pmid=33254510 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33254510 #FOAvip English Wikipedia <ref>{{Cite pmid|33254510}}</ref> Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19? #MMPMID33254510 Avcilar H; Eken A Med Hypotheses 2020[Nov]; 144 (?): 110202 PMID33254510show ga Toll-like receptor 7 is critical in recognition of single strand RNA viruses, including SARS CoV-2, and generation of anti-viral immunity. Coronaviruses evolved strategies to dampen the host immunity. Herein, we discuss the potential use of TLR7 agonists in the early stages of COVID-19 treatment. |*COVID-19 Drug Treatment[MESH] |Adjuvants, Immunologic/administration & dosage/therapeutic use[MESH] |Antiviral Agents/administration & dosage/*therapeutic use[MESH] |COVID-19/immunology[MESH] |Humans[MESH] |Imiquimod/administration & dosage/*therapeutic use[MESH] |Immunity, Innate/drug effects[MESH] |Models, Immunological[MESH] |Pandemics[MESH] |SARS-CoV-2[MESH] |Skin Cream[MESH]Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in th(epmc).pdf DeepDyve Pubget Overpricing